Malignant pleural mesothelioma (MPM) is an aggressive tumor strongly associated with asbestos exposure. Patients are usually diagnosed when current treatments have limited benefits, highlighting the need for noninvasive early diagnostic tests to monitor asbestos-exposed people.
Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects
Guarrera, Simonetta;Viberti, Clara;Cugliari, Giovanni;Allione, Alessandra;Casalone, Elisabetta;Casadio, Caterina;Grosso, Federica;Matullo, Giuseppe
Last
2019-01-01
Abstract
Malignant pleural mesothelioma (MPM) is an aggressive tumor strongly associated with asbestos exposure. Patients are usually diagnosed when current treatments have limited benefits, highlighting the need for noninvasive early diagnostic tests to monitor asbestos-exposed people.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
guarrera_postprint MPM-Meth_JTO_2018.pdf
Open Access dal 01/01/2020
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
1.28 MB
Formato
Adobe PDF
|
1.28 MB | Adobe PDF | Visualizza/Apri |
|
2019_Guarrera.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
897.98 kB
Formato
Adobe PDF
|
897.98 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
